N
Ncardia specializes in human induced pluripotent stem cell (iPSC) technology, providing high-quality cell models and screening assays to enhance drug discovery and development. The company enables therapeutic developers to make informed decisions early in the process, thereby increasing the likelihood of clinical success and reducing development timelines.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Ncardia specializes in human induced pluripotent stem cell (iPSC) technology, providing high-quality cell models and screening assays to enhance drug discovery and development. The company enables therapeutic developers to make informed decisions early in the process, thereby increasing the likelihood of clinical success and reducing development timelines.